Dysregulated SASS6 expression promotes increased ciliogenesis and cell invasion phenotypes

By afschroeder • August 19, 2025

Hargreaves E, Collinson R, Jenks AD, Staszewski A, Tsalikis A, Bodoque R, Arias-Garcia M, Abdi Y, Al-Malki A, Yuan Y, Natrajan R, Haider S, Iskratsch T, Wang WJ, Godinho S, Palaskas NJ, Calvo F, Vivanco I, Zech T, Tanos BE. Dysregulated SASS6 expression promotes increased ciliogenesis and cell invasion phenotypes. Life Sci Alliance. 2025 Aug 18;8(10):e202402820. doi: 10.26508/lsa.202402820. PMID: 40825584.

Tags: Hematology/Oncology, Publications

Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysis

Pontolillo L, Davis AA, Gerratana L, Medford AJ, Wang J, Nicolo' E, Clifton K, Velimirovic M, Warrior S, Podany E, Andreopoulou E, Serafini MS, Munoz-Arcos[...]

Clinical, ethical, and quality-of-life outcomes in unresectable hepatocellular carcinoma: the LEAP-012 trial – Authors’ reply

Kudo M, Ren Z, Finn RS, Llovet JM; LEAP-012 investigators. Clinical, ethical, and quality-of-life outcomes in unresectable hepatocellular carcinoma: the LEAP-012 trial - Authors' reply.[...]

Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial

Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, Sosman JA, In GK, Ikeguchi A, Hyngstrom J,[...]